title: Transfusion-Transmitted Babesiosis During Total Hip Arthroplasty.
abstract: Babesiosis is a potentially life-threatening zoonotic disease that is endemic to the northeastern United States and increasing in prevalence worldwide. Transmitted by the same Ixodes tick responsible for Lyme disease, the intraerythrocytic parasite Babesia causes a wide range of clinical presentations--from asymptomatic carriage to a fulminant course with rapid deterioration. Symptoms typically present 1 to 6 weeks after inoculation, with the gradual onset of fatigue, malaise, weakness, and intermittent or sustained fever as high as 40.9°C. Severe cases are associated with parasitemia greater than 4%, alkaline phosphatase greater than 125 U/L, and white blood cell counts greater than 5×10(9)/L. Definitive diagnosis is made by microscopic examination of thin blood smears, polymerase chain reaction, and indirect immunofluorescent antibody testing. The increasing frequency of babesiosis paired with a lack of blood-donor screening assays poses a serious threat to the safety of the US blood supply. Although babesiosis is responsible for 3.6% of transfusion-related deaths, the Food and Drug Administration has yet to approve mandatory screening for the parasite in donated blood. Historically, transfusion-transmitted babesiosis has been thought to be isolated to the immunocompromised patient population. However, a recent case of transfusion-transmitted babesiosis in an immunocompetent patient following total hip arthroplasty is the first reported in the literature and may represent a growing risk to a far greater segment of the population than previously thought. This article summarizes the current state of transfusion-transmitted babesiosis and the detrimental impact of this infection on blood transfusion safety.
authors.forename: Joseph
authors.initials: J
authors.lastname: Carnevale
authors.forename: Ross
authors.initials: R
authors.lastname: Feller
authors.forename: Robert M
authors.initials: RM
authors.lastname: Shalvoy
mesh_terms: D000368:Aged; D000818:Animals; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects*; D001404:Babesiosis / Q000635:transmission*; D005260:Female; D006801:Humans; D007121:Immunocompetence; D015207:Osteoarthritis, Hip / Q000601:surgery; D016133:Polymerase Chain Reaction; D065227:Transfusion Reaction; D015047:Zoonoses / Q000635:transmission